Expression of Pin1 mRNA in non-small-cell lung cancer patients

Asian Cardiovascular and Thoracic Annals

Volumn 17, Issue 2, 2009, Pages 157-161

  Ai, ZhengHua ^a   Zhang, WeiXing ^a   Luo, WanJun ^a   Huang, LingJin ^a   Pan, Yi ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Reproductive and Genetic Hospital of Citic Xiangya   (China)

Author keywords

Carcinoma; NIMA interacting peptidylprolyl isomerase substance name ; Non small cell lung; Reverse transcriptase polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; TUMOR MARKER; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG VEIN; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIGATION; LUNG SURGERY; LUNG TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEIN; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; UPREGULATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGATION; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEPTIDYLPROLYL ISOMERASE; PULMONARY ARTERY; PULMONARY SURGICAL PROCEDURES; PULMONARY VEINS; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 70349255882     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492309103297     Document Type: Article

References (19)

1. World Health Organization. Global cancer rates could increase by 50% to 15 million by 2020. Available at: http://www.who.int/mediacentre/news/releases/ 2003/pr27/en/. Accessed May 20, 2006.
2. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996;380:544-547 (Pubitemid 26111332)
3. Bayer E, Goettsch S, Mueller JW, Griewel B, Guiberman E, Mayr LM, et al. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J Biol Chem 2003;278:26183-26193
4. Lu KP. Pinning down cell signaling, cancer and Alzheimer's disease [Review]. Trends Biochem Sci 2004;29:200-209
5. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355-365
6. Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997;278:1957-1960
7. Ranganathan R, Lu KP, Hunter T, Noel JP. Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 1997;89:875-886. (Pubitemid 27513514)
8. Lu KP, Liou YC, Zhou XZ. Pinning down the proline-directed phosphorylation signaling [Review]. Trends Cell Biol 2002;12:164-172
9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408 (Pubitemid 34164012)
10. He J, Zhou F, Shao K, Hang J, Wang H, Rayburn E, et al. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 2007;56:51-58 (Pubitemid 46356645)
11. Wulf G, Garg P, Liou YC, Iglehart D, Lu KP. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 2004;23:3397-3407 (Pubitemid 39209163)
12. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Petkova V, et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001;20:3459-3472 (Pubitemid 32634353)
13. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 2004;164:1727-1737 (Pubitemid 38529775)
14. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-393
15. Kurusu Y, Yamashita J, Hayashi N, Mita S, Fujino N, Ogawa M. The sequence of vessel ligation affects tumor release into the circulation. J Thorac Cardiovasc Surg 1998;116:107-113 (Pubitemid 28328634)
16. Ryo A, Liou YC, Wulf G, Nakamura M, Lee SW, Lu KP. Pin1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 2002;22:5281-5295 (Pubitemid 34755742)
17. Rippmann JF, Hobbie S, Daiber C, Guilliard B, Bauer M, Birk J, et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 2000;11:409-416 (Pubitemid 30619568)
18. Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 2003;10:15-24. (Pubitemid 36154470)
19. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, et al. Loss of Pin1 function in the mouse resembles the cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002;99:1335-1340 (Pubitemid 34136494)